Table 4 Characteristics of male participants with vs. without high baPWV in the overall sample

n

995

281

Age , years

52.3 ± 16.2

53.2 ± 13.6

<0.001

baPWV, cm/s

1432 ± 269

1854 ± 424

<0.001

BMI, kg/m ²

24.5 ± 3.3

25.5 ± 2.9

0.069

SBP, mmHg

128.2 ± 15.7

144.4 ± 19.4

<0.001

DBP, mmHg

79.0 ± 26.3

87.6 ± 11.5

<0.001

HR, beats/min

70 ± 10

74 ±11

<0.001

TC, mmol/L

4.7 ± 0.9

4.8 ± 0.9

0.995

HDL-C, mmol/L

1.3 ± 0.3

1.3 ± 0.3

0.870

LDL-C, mmol/L

2.8 ± 0.8

2.9 ± 0.7

0.407

TG, mmol/L

1.8 ± 1.3

1.9 ± 1.3

0.751

Fasting glucose, mmol/L

5.3 ± 1.2

5.9 ± 1.9

<0.001

Hypertension, %

42.4

78.3

<0.001

Diabetes, %

20.7

34.5

<0.001

Smoking, %

47.8

58.1

0.003

Stroke, %

5.7

7.5

0.323

Ischemic heart disease, %

10.5

12.5

0.331

Medication

ACEIs/ARBs usage, %

8.6

14.6

0.005

Statins usage, %

6.8

5.7

0.586

CCBs usage, %

12.8

24.2

<0.001